nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—Intestinal obstruction—Topotecan—cervical cancer	0.0505	0.0796	CcSEcCtD
Gadoxetate—SLCO1B3—vagina—cervical cancer	0.0394	0.108	CbGeAlD
Gadoxetate—Extravasation—Topotecan—cervical cancer	0.0394	0.0622	CcSEcCtD
Gadoxetate—SLCO1B1—renal system—cervical cancer	0.0315	0.086	CbGeAlD
Gadoxetate—Rash maculo-papular—Topotecan—cervical cancer	0.0313	0.0493	CcSEcCtD
Gadoxetate—ABCC3—decidua—cervical cancer	0.0304	0.0831	CbGeAlD
Gadoxetate—ABCC3—renal system—cervical cancer	0.0299	0.0816	CbGeAlD
Gadoxetate—Sepsis—Topotecan—cervical cancer	0.0299	0.0471	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Topotecan—cervical cancer	0.0258	0.0407	CcSEcCtD
Gadoxetate—SLCO1B1—female reproductive system—cervical cancer	0.0252	0.0689	CbGeAlD
Gadoxetate—ABCC4—renal system—cervical cancer	0.0247	0.0674	CbGeAlD
Gadoxetate—ABCC3—female reproductive system—cervical cancer	0.0239	0.0654	CbGeAlD
Gadoxetate—ABCC2—renal system—cervical cancer	0.0239	0.0652	CbGeAlD
Gadoxetate—ABCC4—uterus—cervical cancer	0.022	0.06	CbGeAlD
Gadoxetate—ABCC3—female gonad—cervical cancer	0.0218	0.0595	CbGeAlD
Gadoxetate—ABCC4—female reproductive system—cervical cancer	0.0197	0.0539	CbGeAlD
Gadoxetate—ABCC2—female reproductive system—cervical cancer	0.0191	0.0522	CbGeAlD
Gadoxetate—ABCC4—female gonad—cervical cancer	0.018	0.0491	CbGeAlD
Gadoxetate—Rhinitis—Topotecan—cervical cancer	0.0173	0.0273	CcSEcCtD
Gadoxetate—Hypoaesthesia—Topotecan—cervical cancer	0.0172	0.0271	CcSEcCtD
Gadoxetate—Angiopathy—Topotecan—cervical cancer	0.0157	0.0247	CcSEcCtD
Gadoxetate—Immune system disorder—Topotecan—cervical cancer	0.0156	0.0246	CcSEcCtD
Gadoxetate—Mediastinal disorder—Topotecan—cervical cancer	0.0156	0.0246	CcSEcCtD
Gadoxetate—Chills—Topotecan—cervical cancer	0.0155	0.0245	CcSEcCtD
Gadoxetate—Back pain—Topotecan—cervical cancer	0.0145	0.0229	CcSEcCtD
Gadoxetate—ABCC3—lymph node—cervical cancer	0.014	0.0382	CbGeAlD
Gadoxetate—Ill-defined disorder—Topotecan—cervical cancer	0.014	0.022	CcSEcCtD
Gadoxetate—Malaise—Topotecan—cervical cancer	0.0136	0.0214	CcSEcCtD
Gadoxetate—Cough—Topotecan—cervical cancer	0.0131	0.0207	CcSEcCtD
Gadoxetate—Chest pain—Topotecan—cervical cancer	0.0128	0.0202	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.0127	0.0201	CcSEcCtD
Gadoxetate—Discomfort—Topotecan—cervical cancer	0.0126	0.02	CcSEcCtD
Gadoxetate—Anaphylactic shock—Topotecan—cervical cancer	0.0123	0.0194	CcSEcCtD
Gadoxetate—Infection—Topotecan—cervical cancer	0.0122	0.0192	CcSEcCtD
Gadoxetate—Nervous system disorder—Topotecan—cervical cancer	0.012	0.019	CcSEcCtD
Gadoxetate—Skin disorder—Topotecan—cervical cancer	0.0119	0.0188	CcSEcCtD
Gadoxetate—Hyperhidrosis—Topotecan—cervical cancer	0.0119	0.0187	CcSEcCtD
Gadoxetate—Anorexia—Topotecan—cervical cancer	0.0117	0.0185	CcSEcCtD
Gadoxetate—ABCC4—lymph node—cervical cancer	0.0116	0.0316	CbGeAlD
Gadoxetate—ABCC2—lymph node—cervical cancer	0.0112	0.0305	CbGeAlD
Gadoxetate—Paraesthesia—Topotecan—cervical cancer	0.011	0.0174	CcSEcCtD
Gadoxetate—Dyspnoea—Topotecan—cervical cancer	0.0109	0.0173	CcSEcCtD
Gadoxetate—Decreased appetite—Topotecan—cervical cancer	0.0107	0.0168	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Topotecan—cervical cancer	0.0106	0.0167	CcSEcCtD
Gadoxetate—Fatigue—Topotecan—cervical cancer	0.0106	0.0167	CcSEcCtD
Gadoxetate—Constipation—Topotecan—cervical cancer	0.0105	0.0166	CcSEcCtD
Gadoxetate—Feeling abnormal—Topotecan—cervical cancer	0.0101	0.016	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Topotecan—cervical cancer	0.01	0.0158	CcSEcCtD
Gadoxetate—Urticaria—Topotecan—cervical cancer	0.00975	0.0154	CcSEcCtD
Gadoxetate—Abdominal pain—Topotecan—cervical cancer	0.0097	0.0153	CcSEcCtD
Gadoxetate—Body temperature increased—Topotecan—cervical cancer	0.0097	0.0153	CcSEcCtD
Gadoxetate—Hypersensitivity—Topotecan—cervical cancer	0.00904	0.0143	CcSEcCtD
Gadoxetate—Asthenia—Topotecan—cervical cancer	0.00881	0.0139	CcSEcCtD
Gadoxetate—Pruritus—Topotecan—cervical cancer	0.00868	0.0137	CcSEcCtD
Gadoxetate—Diarrhoea—Topotecan—cervical cancer	0.0084	0.0132	CcSEcCtD
Gadoxetate—Dizziness—Topotecan—cervical cancer	0.00812	0.0128	CcSEcCtD
Gadoxetate—Vomiting—Topotecan—cervical cancer	0.0078	0.0123	CcSEcCtD
Gadoxetate—Rash—Topotecan—cervical cancer	0.00774	0.0122	CcSEcCtD
Gadoxetate—Dermatitis—Topotecan—cervical cancer	0.00773	0.0122	CcSEcCtD
Gadoxetate—Headache—Topotecan—cervical cancer	0.00769	0.0121	CcSEcCtD
Gadoxetate—Nausea—Topotecan—cervical cancer	0.00729	0.0115	CcSEcCtD
